I have only a partial filing (the text cuts off mid-sentence in the Risk Factors section). However, there is sufficient substantive disclosure content to produce an article based on what is available: the cover page, company identity, fiscal year, share count, market cap figure, filer status, and the forward-looking risk factors section.

InnovAge Holding Corp. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 9, 2026, covering the fiscal year ended June 30, 2026.

Key Highlights

  • Shares outstanding: As of September 1, 2026, there were 136,451,425 shares of common stock outstanding, according to the filing.
  • Non-affiliate market cap: The aggregate market value of common stock held by non-affiliates was $111.4 million, based on the closing price on December 31, 2025.
  • Filer classification: The company is classified as an accelerated filer and a smaller reporting company for the fiscal year covered.
  • Exchange listing: Common stock is listed on NASDAQ:INNV under the Nasdaq Global Select Market with a par value of $0.001 per share.
  • SOX 404(b) attestation: The filing indicates the registered public accounting firm has filed a report and attestation on management's assessment of internal control over financial reporting.
  • Proxy incorporation: Portions of the proxy statement for the upcoming Annual Meeting of Stockholders, to be filed no later than 120 days after June 30, 2026, are incorporated by reference into Part III of the report.

InnovAge Reports Fiscal Year 2026 Results and Key Operational Disclosures

InnovAge Holding Corp., a Delaware-incorporated operator of Program of All Inclusive Care for the Elderly ("PACE") centers headquartered at 8950 E. Lowry Boulevard, Denver, CO, submitted its Annual Report on Form 10-K for the fiscal year ended June 30, 2026. The filing is Commission File Number 001-40159. The company disclosed that its common stock had an aggregate market value held by non-affiliates of $111.4 million as of December 31, 2025, the last business day of its most recently completed second fiscal quarter.

According to the filing, there were 136,451,425 shares of common stock outstanding as of September 1, 2026. The company confirmed it is not a shell company, is not an emerging growth company, and has filed all required reports under the Securities Exchange Act of 1934 during the preceding 12 months. The registrant also confirmed it has submitted all required Interactive Data Files electronically during that same period.

The filing includes forward-looking statements that, as the company disclosed, "are subject to risks and uncertainties" and may cause "actual results to differ materially" from expectations. Among the risk factors the company identified are: dependence on government payors and potential reductions in PACE reimbursement rates; ongoing civil investigative demands from federal and state agencies; risks related to risk adjustment score accuracy in government payor submissions; labor shortages and inflationary cost pressures; and the ability to attract and retain PACE participants. The company noted these statements are subject to its cautionary language as set forth in the filing.

What Was Disclosed

InnovAge filed its fiscal year 2026 Form 10-K disclosing 136,451,425 shares outstanding, a $111.4 million non-affiliate market capitalization as of December 31, 2025, accelerated and smaller reporting company status, and a range of operational and regulatory risk factors related to its PACE business.